ANIK Q3 2022 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$40M+1.8% YoY

Gross Profit

$23M56.6% margin

Operating Income

-$6M-14.4% margin

Net Income

-$4M-10.4% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$1M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$348M

Total Liabilities

$63M

Stockholders' Equity

$285M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$40M	+1.8%
Gross Profit	$23M	$23M	-1.1%
Operating Income	-$6M	$1M	-546.0%
Net Income	-$4M	$558,000	-848.2%

Revenue Segments

OA Pain Management

$26M64%

Joint Preservation and Restoration

$12M29%

Non-Orthopedic

$3M7%

Geographic Segments

UNITED STATES

$31M86%

Europe

$5M14%